Skip to product information
1 of 2

BioxList.

2025 US Biotech Investor List – Therapeutics Focus + Direct Emails

2025 US Biotech Investor List – Therapeutics Focus + Direct Emails

Regular price €557,81 EUR
Regular price Sale price €557,81 EUR
Sale Sold out
Taxes included.

Access 266 U.S. Investors Targeted in Therapeutics Innovation. Now with Direct Employee Contacts to Accelerate Your Fundraising.

 

What’s Inside:

🔥Direct Employee Emails: First-name contacts (Partners, Associates, Principals) at Investors' firms.

🏢 Company Names: 266 U.S.-based investors actively investing in Therapeutics (drug discovery, rare diseases, oncology, etc.).

📍Headquarters Locations: Indicates all other countries where their offices also operate.

🌐 Website URLs: Direct access to investor profiles and portfolios.

💸 Investment Stages: Filter by focus (Seed, Series A, etc.) to align with your goals.

💰 Ticket Sizes: Know exact investment ranges (e.g., M) to target the right partners.

📧 Backup Channels: Generic emails included for alternative outreach.

(You’ll receive an Excel file + a CSV file packed with direct partner emails for precision outreach.)

Want an in-depth look at every data point? Click here to discover all the details.

 

Why This List is Made for You:

Stop cold outreach. Pitch Partners directly at firms funding your niche.

Save 100+ hours researching get a curated list of decision-makers who care about your science.

 

Just Results:
This isn’t a generic directory it’s a strategic tool built for accuracy and action. Save hundreds of hours on prospecting, avoid dead-end leads, and focus on what matters: building relationships that drive growth.

 

Download now and unlock 266 strategic connections.

 

Data freshness: Updated April 4 2025

Need specifics? Contact our data team here.

Data sourced from proprietary research

View full details